Literature DB >> 15590085

Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot.

Periklis A Davlouros1, Ageliki A Karatza, Michael A Gatzoulis, Darryl F Shore.   

Abstract

Repaired tetralogy of Fallot (rTOF) has an excellent long-term prognosis; however, survival is somewhat less than normal. Of all the residual lesions and sequellae after rTOF, pulmonary regurgitation (PR) is the most important, correlating with right ventricular (RV) size, exercise intolerance and serious ventricular arrhythmias. Pulmonary valve replacement (PVR) has beneficial effects on RV size and function, provided it is performed early, before irreversible RV dysfunction ensues. Moreover, PVR is associated with an improvement in patients' symptoms and exercise tolerance and combined with arrhythmia surgery (cryoablation) it leads to a dramatic decrease in the incidence of fatal ventricular arrhythmias. Associated lesions, especially branch pulmonary artery stenosis, which aggravates PR, and tricuspid regurgitation, which further impacts on RV size and function, need addressing. Large right ventricular outflow (RVOT) akinetic and aneurysmal regions are frequent and further compromise RV function; therefore, resection during PVR should be attempted. Despite excellent mid-term results, homografts and xenografts, usually used for RVOT reconstruction, suffer late dysfunction and failure, committing patients and surgeons to further operations. Therefore, the decision to operate should be based on the balance between progressive RV dilatation, exercise intolerance, symptoms, arrhythmias and the fact that further reoperations will be needed. Research on the ideal valve for RVOT reconstruction is ongoing. Prospective follow-up of patients with rTOF with exercise testing and assessment of RV size and function, preferably with magnetic resonance, will define better the natural history of the disease and will probably provide firm guidelines for PVR timing especially in asymptomatic patients.

Entities:  

Mesh:

Year:  2004        PMID: 15590085     DOI: 10.1016/j.ijcard.2004.08.013

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  24 in total

1.  Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.

Authors:  Doff B McElhinney; William E Hellenbrand; Evan M Zahn; Thomas K Jones; John P Cheatham; James E Lock; Julie A Vincent
Journal:  Circulation       Date:  2010-07-19       Impact factor: 29.690

2.  Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease.

Authors:  Nicolò Schicchi; Aurelio Secinaro; Giuseppe Muscogiuri; Paolo Ciliberti; Benedetta Leonardi; Teresa Santangelo; Carmela Napolitano; Giacomo Agliata; Maria Chiara Basile; Francesca Guidi; Paolo Tomà; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2015-12-11       Impact factor: 3.469

Review 3.  The right ventricle in congenital heart disease.

Authors:  P A Davlouros; K Niwa; G Webb; M A Gatzoulis
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

4.  Diastolic dysfunction: a new additional criterion for optimal timing of pulmonary valve replacement in adult patient with tetralogy of Fallot?

Authors:  Barbara J M Mulder; Hubert W Vliegen; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

5.  Clinical issues and outcomes in adults following repair of tetralogy of fallot.

Authors:  Bejal Pandya; Michael A Quail; Seamus Cullen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 6.  Pulmonary regurgitation in congenital heart disease.

Authors:  Rajiv R Chaturvedi; Andrew N Redington
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

7.  Pulmonic regurgitation and management challenges in the adult with tetralogy of fallot.

Authors:  Emily Ruckdeschel; Joseph D Kay
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

8.  Triple valve replacement late after tetralogy of Fallot repair: report of a case.

Authors:  Nobuchika Ozaki; Nobuhiko Mukohara; Masato Yoshida; Tsutomu Shida
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Coexistence of mitral regurgitation and pulmonary regurgitation in an adult with surgically corrected tetralogy of Fallot.

Authors:  Dimitrios Z Mytas; Meletios A Kanakis; Lamprini K Kosma; Fotios A Mitropoulos
Journal:  BMJ Case Rep       Date:  2012-12-18

10.  Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia.

Authors:  David M Harrild; Charles I Berul; Frank Cecchin; Tal Geva; Kimberlee Gauvreau; Frank Pigula; Edward P Walsh
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.